May 13th 2025
Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.
May 8th 2025
The program will send 11 young soccer players to learn from professional soccer coaches in Madrid.
May 7th 2025
The campaign provides information about early signs of the condition along with treatment information.
ConnectING with Carnie promotes the importance of routine screening and treatment options for the involuntary movement condition.
May 5th 2025
The company is partnering with McLaren Racing and United Autosports for the event.
Q&A With Daniel Lofaso, CEO of Digital Elevator
Lofaso discusses strategies that biotech companies can take once its time to make the big push.
Kyowa Kirin Purchases Orchard Therapeutics
Transaction made with intent to develop new drugs, company says.
FDA Authorizes Novavax’s COVID-19 Vaccine for Emergency Use
Company expects treatment to be available across the country.
Novartis Launches Sandoz Spinoff, Creating Independent Company
Separate entity allows company to concentrate on status as focused medicines company.
Sanofi, Teva Ink Deal to Develop Inflammatory Bowel Disease Treatment
Collaboration to focus on ulcerative colitis and Crohn’s disease.
Boehringer Ingelheim, Zeiss Partner on Eye Disease Prevention
Joint venture aims to enable early detection of eye diseases and prevent vision loss.
Lilly Set to Obtain Point Biopharma
Acquired company focused on radioligand therapies for the treatment of cancer.
Sanofi, Janssen to Collaborate on Extraintestinal Pathogenic E. Coli Vaccine
Currently in Phase III of clinical trials, Sanofi is expected to commercialize vaccine candidate.
FDA Clears Amicus Therapeutics’ Pompe Disease Treatment
Pombiliti + Opfolda indicated for adults who are not improving on current enzyme therapy.
Viatris, Ocuphire Pharma Receive FDA Approval on Ryzumvi
Eye drop treatment indicated for pharmacologically induced mydriasis.
Merck KGaA, Quris-AI Extend Current Collaboration
Deal comes amid first successful partnership.
Azurity Pharmaceuticals Absorbs Slayback Pharma
Company expects to yield a significant number of new medicine launches from the acquisition.
Ionis, Roche Agree to Terms on Two Early-Stage RNA Programs
Collaboration to focus on Alzheimer’s and Huntington's disease.
Gingko Bioworks, Pfizer Agree to Multi-Target RNA Discovery Collaboration
Ginko will be eligible for up to $331 million in milestone payments.
AcuraStem, Takeda Agree to License Agreement Focused on Advancing PIKfyve Therapeutics
Teams expected to collaborate on development and commercialization of multiple targets.
Alfasigma Set to Obtain Intercept Pharmaceuticals
Transaction expected to close at the end of this year for $19 a share.
Novartis Spin-Off Sandoz Set to Launch Trading on Oct. 4
Shares expected to be offered on Six Swiss Exchange.
Novo Nordisk, Valo Health Partner to Develop Treatments for Cardiometabolic Diseases
Collaboration based on Valo’s large human dataset and computation powered by artificial intelligence.
Lupin Obtains Multiple Legacy Brands from Menarini
Deal comes amid previous exclusive marketing agreement.
MDCalc Launches New Commercial Division
Company brings aboard former Pfizer exec as life sciences COO in effort to help further improve patient outcomes.
LifeMD, Ascend Therapeautics Launch Joint Integrated Telehealth Venture
Project to focus on improving access to EstroGel.
Select Health, Mark Cuban Cost Plus Drug Company Partner on Lowering Prescription Drug Costs
Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.
Abbott, mAbxience Holdings Strike Biosimilars Commercialization Deal
Deal to focus on development and commercialization in key emerging countries.
European Commission Clears Litfulo, Pfizer’s Alopecia Areata Treatment
Medicine indicated for patients aged 12 and older.
Immagene, Aditum Bio Partner to Create New Biotech Company
Celexor Bio expected to focus on ell depletion of pathologic cells in autoimmune and inflammatory disorders.
FDA Rejects ARS Pharmaceuticals’ Needle-Free EpiPen Alternative
Agency cites a need for more research to be completed.
Novo Nordisk Partners with Aspen to Support Insulin Production in Africa
Deal aims to provide diabetes treatment to patients across the continent.
Acino Absorbs M8 Pharmaceuticals
Acquisition offers 300 new employees and a bigger product portfolio.
Paratek Pharmaceuticals Stockholders Approve of Acquisition by Novo Holdings
Deal includes all company assets.
European Commission Clears ViiV Healthcare’s HIV Prevention Treatment
Apretude indicated for high-risk adults and adolescents over 12.